Nontuberculous Mycobacteria Infection Risk and Trace Metals in Surface Water: A Population-based Ecologic Epidemiologic Study in Oregon
- 1 April 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 19 (4) , 543-550
Abstract
Rationale: Nontuberculous mycobacteria (NTM) are ubiquitous environmental bacteria, and some pathogenic species cause lung disease. Environmental factors contribute to increased NTM abundance, with higher potential for exposure and infection. Objectives: To identify water-quality constituents that influence the risk of NTM infection in Oregon. Methods: We conducted a population-based cohort study using patient incidence data from the Oregon statewide NTM laboratory data collected as part of a public health surveillance project from 2007 through 2012. To estimate the risk of NTM pulmonary infection (PI) from exposure to water constituents, we extracted water-quality data from the Water Quality Portal and associated these data with corresponding patient county of residence. Using generalized linear models, we modeled two outcomes: Mycobacterium avium complex species PI and Mycobacterium abscessus group species PI. Results: For every 1-unit increase in the log concentration of vanadium in surface water, infection risk increased by 49% among persons with Mycobacterium avium complex PI. Among those with Mycobacterium abscessus PI, we observed that for every 1-unit increase in the log concentration of molybdenum in surface water, infection risk increased by 41%. The highest risk of infection due to Mycobacterium abscessus group infection was concentrated in counties within the Northwestern region of Oregon. High infection risk associated with Mycobacterium avium complex species did not show any geographic pattern. Conclusions: Concentrations of the trace metals molybdenum and vanadium in surface water sources were associated with NTM infection in Oregon. These findings may help identify regions at higher risk of NTM infection to guide risk reduction strategies.Keywords
Funding Information
- Cystic Fibrosis Foundation (Clinical Pilot and Feasibility Award)
- National Science Foundation (1463642)
- National Science Foundation (1743597)
- National Science Foundation (DGE-1545433)
- Cystic Fibrosis Foundation (Clinical Pilot and Feasibility Award)
- National Science Foundation (1463642)
- National Science Foundation (1743597)
- National Science Foundation (DGE-1545433)
This publication has 31 references indexed in Scilit:
- Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare BeneficiariesAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Molybdenum limitation of microbial nitrogen assimilation in aquatic ecosystems and pure culturesFrontiers in Microbiology, 2012
- Comparative analysis of mycobacterium and related actinomycetes yields insight into the evolution of mycobacterium tuberculosis pathogenesisBMC Genomics, 2012
- Pulmonary Disease Associated with Nontuberculous Mycobacteria, Oregon, USAEmerging Infectious Diseases, 2011
- Functional Analysis of Molybdopterin Biosynthesis in Mycobacteria Identifies a Fused Molybdopterin Synthase in Mycobacterium tuberculosisJournal of Bacteriology, 2011
- Pulmonary Nontuberculous Mycobacterial Disease Prevalence and Clinical Features: An Emerging Public Health DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Glycine Betaine Uptake by the ProXVWZ ABC Transporter Contributes to the Ability ofMycobacterium tuberculosisTo Initiate Growth in Human MacrophagesJournal of Bacteriology, 2008
- The ATP binding cassette (ABC) transport systems ofMycobacterium tuberculosisFEMS Microbiology Reviews, 2000
- Epidemiology of Infection by Nontuberculous Mycobacteria: Mycobacterium avium, Mycobacterium intracellulare , and Mycobacterium scrofulaceum in Acid, Brown-Water Swamps of the Southeastern United States and Their Association with Environmental VariablesAmerican Review of Respiratory Disease, 1992
- In vitro susceptibility of human and environmental isolates of Mycobacterium avium, M. intracellulare, and M. scrofulaceum to heavy-metal salts and oxyanionsAntimicrobial Agents and Chemotherapy, 1984